Exosomal MicroRNA‐27a Passenger Strand Was Upregulated in Chronic Heart Failure

Changhai Tian,Lie Gao,Irving H. Zucker
DOI: https://doi.org/10.1096/fasebj.2018.32.1_supplement.903.7
2018-01-01
Abstract:Under cardiac stress, the heart undergoes extensive cardiac remodeling that results in cardiac fibrosis and hypertrophy, which contribute to chronic heart failure (CHF). Data from our lab revealed that microRNA‐27a contributes to the Nrf2 translational inhibition in cardiomyocytes through the communication with cardiac fibroblast‐derived exosomes. Interestingly, microRNA‐27a passenger strand (also call microRNA‐27a*) in infarcted cardiac tissues and extracellular exosomes shows a relatively high abundance which normally undergoes intracellular degradation (Figure. 1). However, the role of microRNA‐27a* in the onset and progression of CHF remains unclear. A bioinformatics analysis using TargetScan software revealed that PDZ and LIM domain 5 (PDLIM5) is one of potential targets of miroRNA‐27a*, and cardiomyocyte‐specific PDLIM5 knock‐out mice have been shown to develop cardiomyopathy, suggesting that PDLIM5 plays a major role in cardiac muscle structure and function, and may contribute to the progression of cardiomyocyte hypertrophy. Thus, we hypothesize that microRNA‐27a* may regulate PDLIM5 through exosomal communication with cardiomyocytes in chronic heart failure. Using western blotting analysis, we demonstrate down‐regulation of PDLIM5 in the infarcted heart compared to normal heart (Figure. 2), which correlated with the alterations of microRNA‐27a* in both of infarcted heart tissue and plasma. Additionally, our in vitro cell culture studies demonstrate that extracellular exosomes secreted by angiotensin II‐treated cardiac fibroblasts enriched abundant microRNA‐27a*, which promoted hypertrophic gene expression in cardiomyocytes. These findings suggest that exosomal microRNA‐27a* secreted by cardiac fibroblasts in response to cardiac stress, may act as a paracrine signaling mediator of cardiomyocyte remodeling that has potential as a therapeutic target and one of diagnostic markers.Support or Funding InformationThis work was supported by National Institutes of Health National Heart, Lung, and Blood Institute grant PO1 HL 62222 (IHZ)This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
What problem does this paper attempt to address?